Doctor profile · Federal record

Dr. Nafisa Burhani, MD

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Joliet, IL

  • NPI 1851386460
  • Accepts Medicare
  • 35 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2614 W Jefferson St
Joliet, IL 60435
(815) 725-1355
fax (815) 725-9857
Mailing address
Po Box 713260
Chicago, IL 606771260

Credentials & registration

NPPES · NUCC
NPI registered
September 2005 — 21 yrs on file
Profile last updated
August 4, 2023
Year of graduation
1991 — 35 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Illinois #036089567
Medicaid
IL #036089567

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1851386460. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
36,648
Distinct HCPCS
10
Medicare allowed
$281,978
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 18,360 18 $1
J1453 Injection, fosaprepitant, 1 mg 5,250 16 $0
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units 4,610 28 $8
J0897 Injection, denosumab, 1 mg 2,640 24 $23
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 938 393 $8
80053 Blood test, comprehensive group of blood chemicals 789 378 $10
36415 Insertion of needle into vein for collection of blood sample 703 341 $8
J1100 Injection, dexamethasone sodium phosphate, 1 mg 566 21 $0
J2469 Injection, palonosetron hcl, 25 mcg 400 18 $1
99214 Established patient office or other outpatient visit, 30-39 minutes 289 220 $129

In context: peer comparison

Among 2 peers in Joliet Hematology & Oncology Physician, average services per provider: 941. This provider delivers 39× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,213
Transactions
35
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Lilly USA, LLC 2 $100.89
Pfizer INC. 5 $96.19
Novartis Pharmaceuticals Corporation 5 $95.83
AstraZeneca Pharmaceuticals Lp 4 $94.23
Merck Sharp & Dohme LLC 3 $78.85
Regeneron Healthcare Solutions, INC. 2 $56.95
Takeda Pharmaceuticals U.S.A., INC. 2 $52.21
Janssen Biotech, INC. 2 $47.79
Genentech USA, INC. 2 $47.68
Bayer Healthcare Pharmaceuticals INC. 2 $46.27
Jazz Pharmaceuticals INC. 1 $39.11
Ipsen Biopharmaceuticals, INC 1 $34.88
E.R. Squibb & Sons, L.L.C. 2 $28.98
Mirati Therapeutics, INC. 1 $28.84
Genzyme Corporation 1 $27.97

By nature of payment

Food and Beverage
$1,132
Education
$80

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
404
Patients
143
Total drug cost
$360,184
Drug Type Claims Patients Total cost
Letrozole Generic 73 27 $4,551
Eliquis (Apixaban) Brand 50 20 $46,393
Warfarin Sodium Generic 47 17 $508
Anastrozole Generic 45 21 $1,278
Dexamethasone Generic 35 20 $499
Acyclovir Generic 28 0 $744
Potassium Chloride Generic 22 14 $1,358
Prochlorperazine Maleate Generic 21 12 $247
Ibrance (Palbociclib) Brand 18 0 $281,899
Xarelto (Rivaroxaban) Brand 18 0 $21,424

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Nafisa Burhani's medical specialty?
Dr. Nafisa Burhani practices Hematology & Oncology Physician in Joliet, IL.
Where does Dr. Nafisa Burhani practice?
Dr. Nafisa Burhani practices at 2614 W Jefferson St, Joliet, IL 60435. Office phone: 8157251355.
What is Dr. Nafisa Burhani's NPI?
Dr. Nafisa Burhani's National Provider Identifier (NPI) is 1851386460, issued by NPPES.
Does Dr. Nafisa Burhani accept Medicare assignment?
Yes. Dr. Nafisa Burhani accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Nafisa Burhani commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS Q5106). Source: CMS Medicare Physician & Other Practitioners file.